AstraZeneca reports positive phase 3 data for tozorakimab in COPD
COPD affects nearly 400 million people globally and is the third leading cause of death worldwide
Read More
COPD affects nearly 400 million people globally and is the third leading cause of death worldwide
Read MoreApr 28, 2026 | News, Regulatory
The approval offers a new RSV prevention option for infants
Read MoreApr 27, 2026 | News, Healthcare
The acquisition will help Lilly to expand its capabilities in cell and gene therapy
Read MoreApr 27, 2026 | News, Regulatory
SMA is a rare genetic neuromuscular condition affecting around 1,600 people in the UK
Read MoreApr 24, 2026 | News, Regulatory
Plaque psoriasis affects over 125 million people worldwide
Read MoreALS is a progressive neurodegenerative disease that affects the motor neurons of the brain and spinal cord
Read MoreParkinson’s disease affects over six million people globally
Read MoreThe rare disease affects around one in every 22,000 people worldwide
Read MoreApr 20, 2026 | News, Regulatory
Bladder cancer affects over 224,000 people annually in Europe, with over 30% of cases being muscle-invasive bladder cancer
Read MoreApr 17, 2026 | News, Healthcare
With a 10-day ceasefire between Israel and Lebanon in effect, oil prices are retreating from recent highs
Read MoreApr 17, 2026 | News, Regulatory
The company has been given manufacturing and marketing authorisation for the therapy
Read MoreApr 17, 2026 | News, Healthcare
Spanning four dimensions of skin health, the framework introduces 15 terms and definitions
Read More
